Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New appointment at Transcept Pharmaceuticals

This article was originally published in Scrip

Executive Summary

Joseph Kennedy has been appointed vice-president, general counsel and secretary at Transcept Pharmaceuticals (US). He has more than 15 years' legal experience representing pharmaceutical companies, developing life science companies, investment banks and venture capital firms. Mr Kennedy served as vice-president and acting chief legal officer, and previously chief corporate counsel, of Eyetech Pharmaceuticals. Before that, he worked as vice-president and US counsel, corporate business development, at Elan. Transcept completed a merger with Novacea in January.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC001163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel